Omega Diagnostics Group PLC are pleased to announce that Visitect CD4 has been chosen for the inaugural Nominet Trust 100 – a list that celebrates the people and organisations who are utilising digital technology to change the world for the better. Visitect CD4 was selected from hundreds of nominations reviewed by the Nominet Trust 100 Steering Group, which this year included; Lord Jim Knight (a consultant specialising in the use of technology in education and employment), Rory Cellan-Jones (Technology Journalist for the BBC), Madhav Chavan (a leading Indian educator, social activist and social entrepreneur) and Jeremy Heimans (Founder and CEO of Purpose). We hope you will join us in celebrating this great achievement.